Fresnes, France

Didier Desmaele

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Didier Desmaele

Introduction

Didier Desmaele is a prominent inventor based in Fresnes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents and cancer treatments. With a total of nine patents to his name, Desmaele's work has had a considerable impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents, one notable invention is focused on antiviral agents directed against respiratory syncytial virus. This invention relates to N1-benzyl substituted pyrazoles, which serve as effective antiviral agents. Another significant patent involves derivatives of oxazaphosphorines that are pre-activated. This invention details the methods for preparing these derivatives, the pharmaceutical compositions containing them, and their therapeutic use, particularly in treating cancer.

Career Highlights

Desmaele has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Institut Gustave Roussy. His career has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout his career, Desmaele has collaborated with notable professionals in the field, including Patrick Couvreur and Jean D'Angelo. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Didier Desmaele's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the development of effective treatments for viral infections and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…